ScoutQuest23 Oct 2026
Strides Pharma Science532531Board meeting scheduled

Board meeting on October 29, 2026 to consider and approve unaudited results for Q2 and H1

Board meeting scheduled for Thursday, October 29, 2026.

By ScoutQuest · · 1 min read

Board meeting date
Thursday, October 29, 2026
Purpose
to consider and approve the unaudited financial results (standalone and consolidated) for the quarter and half year ended September 30, 2026
Trading window
closed from October 1, 2026; to open 48 hours after the results are declared

Board meeting scheduled

Trading window

Why this matters to a retail investor

This is a routine advance notice that fixes the date on which the company's September-quarter numbers will be taken up by the board. Investors typically watch this date because the results themselves — revenue, profitability, segment performance — become public around it. The update itself contains no financial figures for the quarter; it only sets out the date and the purpose of the meeting.

The trading window closure is an internal restriction that applies to Designated Persons of the company around the results announcement. It is a standard pre-results practice and applies to those covered by the company's code.

The company has confirmed the information will also be available on its website, www.strides.com.

More numbers
  • Trading window re-opening gap after results declaration48 hours
Source: BSE · 23 Oct 2026

Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.

About ScoutQuest · Logos provided by Logo.dev